Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Amazon RIVR is a robotics company pioneering Physical AI through real-world doorstep delivery. Founded in 2024 as an ETH Zurich spin-off, RIVR developed wheeled-legged robots designed to operate in complex, unstructured environments such as stairs, gates,